Trial Profile
Effectiveness of MP29-02 for the treatment of allergic rhinitis in real-life: Results from a noninterventional study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Dec 2015
Price :
$35
*
At a glance
- Drugs Azelastine/fluticasone-propionate (Primary)
- Indications Perennial allergic rhinitis; Seasonal allergic rhinitis
- Focus Adverse reactions; Therapeutic Use
- 08 Dec 2015 New trial record